Watchlist Price Alert

Intercept Pharmaceuticals... (ICPT)

NASDAQ: ICPT · Real-Time Price · USD

19.00

0.04 (0.21%)

At close: Nov 07, 2023, 9:00 PM

Intercept Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-174.86M	-91.43M	-274.88M	-344.68M	-309.24M	-360.37M	-412.83M
Depreciation & Amortization	592K	2.98M	3.12M	3.66M	4.58M	4.6M	3.83M
Stock-Based Compensation	21.89M	33.89M	60.85M	55.98M	49.91M	56.97M	46.2M
Other Working Capital	-3.45M	-2.68M	-8.95M	-23.38M	-358K	-6M	-116K
Other Non-Cash Items	103.68M	39.11M	34.65M	26.71M	15.57M	18.75M	11.91M
Deferred Income Tax	n/a	-11.78M	4.24M	2.38M	1.31M	4.43M	4.99M
Change in Working Capital	21.92M	-14.42M	2M	19.33M	-2.85M	14.65M	8.44M
Operating Cash Flow	-26.78M	-41.64M	-170.03M	-236.61M	-240.71M	-265.4M	-342.44M
Capital Expenditures	-568K	-397K	-3.89M	-1.14M	-167K	-10.39M	-5.08M
Cash Acquisitions	n/a	-71.12M	-166.71M	187.85M	n/a	n/a	n/a
Purchase of Investments	-552.74M	-349.46M	-330.71M	-603.01M	-436.07M	-231.11M	-511.52M
Sales Maturities Of Investments	451.92M	420.58M	497.42M	415.16M	388.17M	529.27M	456.46M
Other Investing Acitivies	363.23M	71.12M	166.71M	-187.85M	-47.9M	298.17M	-55.06M
Investing Cash Flow	261.85M	70.73M	162.82M	-188.99M	-48.07M	287.77M	-60.13M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	-557K	-75.83M	-1.99M	-2.16M	-2.18M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-267.32M	1.12M	-693K	457.52M	263.55M	2.84M	414.38M
Financial Cash Flow	-267.32M	1.12M	-693K	457.52M	263.55M	2.84M	414.38M
Net Cash Flow	-38.55M	28.75M	-9.13M	31.53M	-26.77M	26.34M	10.93M
Free Cash Flow	-27.35M	-42.04M	-173.92M	-237.75M	-240.88M	-275.79M	-347.52M